title: Use of the Tego needlefree connector is associated with reduced incidence of catheter-related bloodstream infections in hemodialysis patients.
abstract: OBJECTIVE
  Catheter-related bloodstream infections (CRBSIs) are common in hemodialysis patients using central venous catheters, and catheter occlusion also occurs frequently. The Tego needlefree connector was developed to reduce the incidence of these complications; however, existing studies of its effectiveness and safety are limited.
  
  
  METHODS
  This retrospective analysis compared outcomes among patients of a large dialysis organization receiving in-center hemodialysis using a central venous catheter with either the Tego connector or standard catheter caps between October 1 and June 30, 2013. Incidence rates for intravenous (IV) antibiotic starts, receipt of an IV antibiotic course, positive blood cultures, mortality, and missed dialysis treatments were calculated, and incidence-rate ratios (IRRs) were estimated using Poisson regression models. Utilization of erythropoiesis-stimulating agents (ESAs) and thrombolytics was described for each patient-month and compared using mixed linear models. Models were run without adjustment, adjusted for covariates that were imbalanced between cohorts, or fully adjusted for all potential confounders.
  
  
  RESULTS
  The analysis comprised 10,652 Tego patients and 6,493 controls. Tego use was independently associated with decreased risk of CRBSI, defined by initiation of IV antibiotics (adjusted IRR 0.92, 95% confidence interval [CI] 0.87-0.97) or initiation of IV antibiotic course (adjusted IRR 0.89, 95% CI 0.84-0.95). Tego use was independently associated with decreased rate of missed dialysis treatments (adjusted IRR 0.98, 95% CI 0.97-1.00); no significant difference between Tego and control cohorts was observed with respect to mortality. Tego use was associated with decreased likelihood of thrombolytic use (adjusted per-month probability of 5.6% versus 6.2% for controls) and lower utilization of ESAs in study months 7-9.
  
  
  CONCLUSIONS
  Use of the Tego connector may reduce the risk of CRBSI and result in lower utilization of thrombolytics, antibiotics, and ESAs, as well as fewer missed dialysis treatments.
authors.affiliation: DaVita Clinical Research®, Minneapolis, MN, USA.
authors.forename: Steven M
authors.initials: SM
authors.lastname: Brunelli
authors.affiliation: DaVita HealthCare Partners, Inc, Denver, CO, USA.
authors.forename: Levi
authors.initials: L
authors.lastname: Njord
authors.affiliation: DaVita Clinical Research®, Minneapolis, MN, USA.
authors.forename: Abigail E
authors.initials: AE
authors.lastname: Hunt
authors.affiliation: DaVita Clinical Research®, Minneapolis, MN, USA.
authors.forename: Scott P
authors.initials: SP
authors.lastname: Sibbel
keywords: ESA; catheter; dialysis; end-stage renal disease; infection; mortality
references.citation: Nephrol Dial Transplant. 2006 Aug;21(8):2247-55
references.pmid: 16627606
references.citation: Hemodial Int. 2013 Jan;17(1):86-93
references.pmid: 22742528
references.citation: Am J Kidney Dis. 2007 Sep;50(3):379-95
references.pmid: 17720517
references.citation: Nephrol Nurs J. 2010 Sep-Oct;37(5):541-4; quiz 545
references.pmid: 20973308
references.citation: J Chronic Dis. 1987;40(5):373-83
references.pmid: 3558716
references.citation: Am J Kidney Dis. 2013 Mar;61(3):459-65
references.pmid: 23228946
references.citation: Blood Purif. 2006;24(4):387-93
references.pmid: 16755161
references.citation: Fed Regist. 2013 Dec 2;78(231):72155-253
references.pmid: 24294636
references.citation: Semin Dial. 2008 Sep-Oct;21(5):490-2
references.pmid: 18764795
references.citation: Infect Immun. 2005 Aug;73(8):4596-606
references.pmid: 16040971
references.citation: Am J Kidney Dis. 2011 Aug;58(2):235-42
references.pmid: 21664016
references.citation: N Engl J Med. 2003 Mar 20;348(12):1123-33
references.pmid: 12646670
references.citation: Hemodial Int. 2009 Apr;13(2):222-34
references.pmid: 19432697
references.citation: J Intern Med. 1999 Sep;246(3):325-9
references.pmid: 10476001